Authors: Tareeva, IE Kutyrina, IM Nikolaev, AY Lifshits, NL Shvetsov, MY

Citation: Ie. Tareeva et al., Ways to inhibit development of chronic renal failure, TERAPEVT AR, 72(6), 2000, pp. 9-14

Authors: Dzgoeva, FU Kutyrina, IM

Citation: Fu. Dzgoeva et Im. Kutyrina, Thromboxane A(2) and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protectiveeffects of calcium antagonists, TERAPEVT AR, 72(6), 2000, pp. 42-45

Authors: Kutyrina, IM Tareeva, IE Nosikov, VV Kamyshova, ES Gorashko, NM Chistyakov, DA Okonova, EB Troepolskaya, OV

Citation: Im. Kutyrina et al., Polymorphism studies of angiotensin-converting enzyme in chronic glomerulonephritis, TERAPEVT AR, 71(6), 1999, pp. 30-34

Authors: Lifshits, NL Kutyrina, IM

Citation: Nl. Lifshits et Im. Kutyrina, Role of renin-angiotensin-aldosteron system in pathogenesis of arterial hypertension in chronic renal failure, TERAPEVT AR, 71(6), 1999, pp. 64-67

Authors: Dzgoeva, FU Kutyrina, IM Burgova, EN Salbiev, KD Vanin, AF

Citation: Fu. Dzgoeva et al., Decrease in kidney nitric oxide formation detected by electron paramagnetic resonance in acute renal failure due to contrast media, NEPHRON, 81(4), 1999, pp. 441-441